She won it! The Max Foundation is thrilled to announce that Pat Garcia-Gonzalez has won the Union for International Cancer Control’s CEO Award for 2018!
The Union for International Cancer Control (UICC) is a membership organization that aims to reduce the global cancer burden and promote greater equity in cancer care. Each year the UICC grants awards that aim to identify and celebrate best practices and inspirational figures among their members.
Pat received the CEO Award at this year’s World Cancer Congress in Kuala Lumpur, for her tremendous contributions to equity in cancer care and her visionary leadership as Chief Executive Officer of The Max Foundation. She was cheered on by friends, colleagues, and Max team members from around the globe.
Said Pat: “It is such an honor to receive this award, but it is not only for me. It’s really for the entire Max team and for all our many partners. My thanks go out to them for their daily efforts in making The Max Foundation possible and working tirelessly to create a world where all people can face cancer with dignity and hope.”
Pat had been one of three finalists for the award, alongside Asem Mansour of King Hussein Cancer Center in Jordan, and Wondu Bekele Woldemariam of Mathiwos Wondu-YeEthiopia Cancer Society. Our thanks and congratulations go out to all three finalists.
The Max Foundation would like to thank all our partners – physicians, pharmaceutical manufacturers, distribution and diagnostics companies, donors and supporters, and of course, patient associations – we could not do what we do with you.
Most of all, we’d like to thank the 18 different patient associations from across Asia that sent letters in support of Pat’s nomination. You are the inspiration for all we do and we are so very grateful for your support.
Visit the UICC website to learn more about the awards, the finalists, and our collective work to reduce the global cancer burden.
The Max Foundation is a leading global health nonprofit organization dedicated to accelerating health equity. For 27 years, Max has pioneered practical, scalable, high-quality solutions to bring life-extending treatments and patient-centered health care to more than 100,000 people living with cancer and critical illness in low- and middle-income countries. Max believes in a world where all people can access high-impact medicines, where geography is not destiny, and where everyone can strive for health with dignity and with hope.
Related Articles
The Max Foundation (Max) Expands Collaboration with Novartis to Include Access to Innovative Treatment for Paroxysmal Nocturnal Hemoglobinuria (PNH)
Max to immediately begin process to provide humanitarian access for Fabhalta® (iptacopan) in collaboration with its network of partner hematologists across 53 countries People living with the rare blood disease in low-middle income countries require frequent blood transfusions, experience debilitating symptoms of fatigue and without treatment may progress to more serious life-threatening diseases The Max….
The Max Foundation Partners with Leading Pharmaceutical Company to Advance Health Equity Through Expanded CML Treatment Access for Patients in 36 Low-Middle-Income Countries
Availability of Novartis Scemblix® (asciminib) starting in 2023 helps ensure people living with later lines of CML in low-income countries have access to the latest innovation SEATTLE – Dec. 12, 2022 – The Max Foundation (Max), a global nonprofit organization that aims to accelerate health equity by delivering medication, technology, and supportive services to patients globally,….
It was heartwarming looking at my son Max’s picture at the Patan Hospital: Pat Garcia-Gonzalez
Read the interview with the Nepal Live Today – October 21, 2024.
Popup - New
The Max Foundation uses cookies to improve your experience on our site. Please read our Privacy Policy for more information.Dismiss
